Maravai LifeSciences Holdings, Inc. (MRVI)
NASDAQ: MRVI · Real-Time Price · USD
4.850
+0.910 (23.10%)
At close: May 8, 2026, 4:00 PM EDT
4.720
-0.130 (-2.68%)
After-hours: May 8, 2026, 7:58 PM EDT
Maravai LifeSciences Holdings Employees
Maravai LifeSciences Holdings had 435 employees as of December 31, 2025. The number of employees decreased by 135 or -23.68% compared to the previous year.
Employees
435
Change
-135
Growth
-23.68%
Revenue / Employee
$470,644
Profits / Employee
-$240,370
Market Cap
1.25B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 435 | -135 | -23.68% |
| Sep 30, 2025 | 550 | -30 | -5.17% |
| Jun 30, 2025 | 560 | -20 | -3.45% |
| Mar 31, 2025 | 580 | 10 | 1.75% |
| Dec 31, 2024 | 570 | -80 | -12.31% |
| Sep 30, 2024 | 580 | -90 | -13.43% |
| Jun 30, 2024 | 580 | -80 | -12.12% |
| Mar 31, 2024 | 570 | -80 | -12.31% |
| Dec 31, 2023 | 650 | 40 | 6.56% |
| Sep 30, 2023 | 670 | 70 | 11.67% |
| Jun 30, 2023 | 660 | 110 | 20.00% |
| Mar 31, 2023 | 650 | 130 | 25.00% |
| Dec 31, 2022 | 610 | 140 | 29.79% |
| Sep 30, 2022 | 600 | 140 | 30.43% |
| Jun 30, 2022 | 550 | 60 | 12.24% |
| Mar 31, 2022 | 520 | 60 | 13.04% |
| Dec 31, 2021 | 470 | 60 | 14.63% |
| Sep 30, 2021 | 460 | 50 | 12.20% |
| Jun 30, 2021 | 490 | - | - |
| Mar 31, 2021 | 460 | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Zenas BioPharma | 167 |
| MapLight Therapeutics | 133 |
| Olema Pharmaceuticals | 131 |
| MoonLake Immunotherapeutics | 130 |
| DBV Technologies | 117 |
| GH Research | 73 |
| Savara | 70 |
| Jade Biosciences | 55 |
MRVI News
- 1 day ago - Maravai Lifesciences price target raised to $6 from $4.50 at Deutsche Bank - TheFly
- 2 days ago - Maravai LifeSciences Holdings Earnings Call Transcript: Q1 2026 - Transcripts
- 2 days ago - Maravai LifeSciences Reports First Quarter 2026 Financial Results - Business Wire
- 19 days ago - Maravai LifeSciences To Host Earnings Conference Call on Thursday, May 7, 2026 - Business Wire
- 2 months ago - Maravai Lifesciences price target raised to $3 from $2 at Baird - TheFly
- 2 months ago - Maravai LifeSciences Holdings Earnings Call Transcript: Q4 2025 - Transcripts
- 2 months ago - Maravai Lifesciences Reports Fourth Quarter and Full Year 2025 Financial Results - Business Wire
- 3 months ago - Maravai LifeSciences To Host Earnings Conference Call on Wednesday, February 25, 2026 - Business Wire